Availability and Utilization of WHO Lifesaving Medicines for Children

Availability and Utilization of WHO Lifesaving Medicines for Children

Hindawi International Journal of Pediatrics Volume 2020, Article ID 3505672, 10 pages https://doi.org/10.1155/2020/3505672 Research Article Availability and Utilization of WHO Lifesaving Medicines for Children under Five in Public Health Facilities of the Jimma Zone, South West Ethiopia: A Cross-Sectional Survey Tidenek Mulugeta Tujo and Tadesse Gudeta Gurmu School of Pharmacy, Institute of Health, Jimma University, Ethiopia Correspondence should be addressed to Tidenek Mulugeta Tujo; [email protected] Received 30 December 2019; Accepted 12 May 2020; Published 1 June 2020 Academic Editor: Samuel Menahem Copyright © 2020 Tidenek Mulugeta Tujo and Tadesse Gudeta Gurmu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. The increased morbidity and mortality rates in children under five in developing countries are mostly attributed to poor availability and failure of prescribing lifesaving medicines. This study was aimed at evaluating the availability and utilization of the WHO-recommended priority lifesaving medicines for children under five in public health facilities. Method.A cross-sectional survey complemented with a qualitative method was conducted in 14 health centers and four hospitals in the Jimma Zone, Ethiopia. In the facilities, we assessed the availability within the last half year and on the day of the visit. Utilization of the medicines was assessed through a review of patient records of the last one year. Twelve in-depth interviews were carried out to collect the qualitative data, and the analysis was executed using thematic analysis. Results. For treatment of pneumonia, amoxicillin dispersible tablets and gentamycin injection were available in 94.4% of the facilities. For treatment of malaria, artemether/lumefantrine was available in 61.1% of the facilities. For pain management, paracetamol tablets were available in 94.4% of the facilities. AZT+3TC+NEV for HIV/AIDS management was available in all facilities. At least one essential medicine was out of stock in the past six months with the average duration of 33.6 days in health centers and 28.25 days in hospitals. Oral rehydration salt and zinc (84.7%) and AZT+3TC+NEV (100%) had better utilization. However, for almost all cases, other nonpriority medicines were highly prescribed. Lack of administrative commitment, supply of near expiry products, complexity of diseases, and lack of customized child formulations were among the challenges of availability and utilization of those medicines. Conclusions. The overall availability of lifesaving medicines on the day of the visit was fairly good but with poor utilization in almost all facilities. Some products were not available for considerable length of time in the past six months. 1. Background The World Health Organization (WHO) reported that the majority of the morbidities in children under five are pre- According to UNICEF’s (United Nations International Chil- ventable or treatable if lifesaving medicines are available and dren’s Emergency Fund) report, globally, there is notable consistently utilized [2]. To tackle this problem, the WHO, progress in child survival observed in the past few decades. United Nations Population Fund (UNFPA), and UNICEF Millions of children have better survival chances than those have jointly developed a list of priority medicines. The list in 1990. One in twenty-six children died before reaching identified malaria, pneumonia, sepsis, pain, diarrhea, HIV, the age of five in 2017, compared to one in eleven in 1990. and vitamin A deficiency as the leading causes of morbidity Despite the global progress in reducing child mortality, an in children under five [3]. estimated 5.4 million children under the age of five died in Making lifesaving medicines available in different facili- 2017. Roughly half of those deaths occurred in sub-Saharan ties contributes a lot to reducing the newborn and child mor- Africa [1]. bidity and mortality [4]. However, availability of a product 2 International Journal of Pediatrics 118 public health facilities (hospitals (Hs)and health centers (HCs) Stratified sampling technique Lower-level health facilities, Higher-level health facilities. 111 HCs Stratified sampling Clustered into 18 districts technique Purposive sampling Specialized District hospital Zonal hospital 14 HCs which provide HIV hospital (one) (five) (one) service One specialized hospital, two district hospitals, and one zonal 18 health facilities (health hospital selected (4 Hs) centers and hospitals) Figure 1: Flow diagram showing the health facility selection procedure. solely will not be a guarantee to achieve the target of the ing medicines for children under five are scarce. On top of products. In addition to ensuring availability, it is also impor- that, little is known about the utilization of those medicines. tant to assess and verify whether the medications are being Even the available limited studies relied on the prescriber’s prescribed or not [5]. self-report to evaluate the medicine utilization practice. Medicines are among the most effective and widely used Therefore, the aim of the present study was to evaluate the therapeutic interventions in health care today. Despite this availability and utilization of WHO lifesaving medicines for important role of medicines, it is difficult to realize their role children under five. without knowing the health practitioners’ habit of prescrib- ing the recommended medicines. Information on this is the 2. Methods anchor of any system to produce the desired effects [6]. Nonavailability of priority medicines pushes health 2.1. Study Design and Setting. A cross-sectional survey com- care providers to prescribe alternative medicines. Such an plemented with a qualitative method was conducted in approach may finally end up with treatment failure and asso- selected public health facilities in the Jimma Zone from ciated increased consultation rates [7]. On the other hand, March 5 to April 9, 2018. The Jimma Zone is geographically though the products are available physically, failure to pre- located to the southwest of Ethiopia, 350 km away from the scribe them particularly reduces the quality of medical care capital city of the country, Addis Ababa. It is administratively and leads to the wastage of resources [8]. subdivided into 18 districts, namely, Agaro Town, Chora According to the report of the United Nations (UN) Botor, Dedo, Gera, Gomma, Guma, Kersa, Limmu Kosa, commission, two of the issues facing developing countries Limmu Sakka, Mana, Omo Nada, Seka Chekorsa, Setema, include insufficient supplies of health commodities and asso- Shebe Senbo, Sigmo, Sokoru, Tiro Afeta, and Jimma Town. ciated utilization problems [9]. Currently, the zone has a total of 630 public health facilities, A cross-sectional survey conducted in 32 lower-level i.e., seven hospitals, 111 health centers, and 512 health posts public facilities in Jinja District of Uganda showed that the giving service to the community. The Ethiopian pharmaceu- availability and utilization of priority lifesaving medicines tical supply agency Jimma hub is the main source of medi- for pneumonia and malaria are low. However, the priority cines for these public health facilities. Three thousand and medicines for diarrhea and sepsis were available and highly nine hundred ninety health professionals of different fields prescribed by the health workers [10]. Similar lower avail- had been serving in those facilities [13]. ability of children’s essential medicine was reported in West- ern Ethiopia and Guatemala [11, 12]. 2.2. Source Population and Study Units. The source popula- The majority of previous studies focused mostly on the tion of the current study was all health facilities, health evaluation of essential medicine availability for a general workers, logistics documents, and medicines. The study units pediatric population. However, studies specifically address- were WHO-recommended priority lifesaving medicines, International Journal of Pediatrics 3 selected public hospitals, and health centers. The study cations [15]. Accordingly, for HIV, AZT+3TC+NEV, AZT+ observations include bin cards, patient cards, and selected 3TC, NVP, ABC+3TC, 3TC, LPV/r, and EVF were included. health professionals. Document reviews were also performed to gather essen- tial data. We reviewed bin cards to evaluate stockout rates 2.3. Inclusion and Exclusion Criteria in the past six months and patient cards to determine the uti- lization of lifesaving medicines. The number of bin cards was 2.3.1. Inclusion Criteria. To capture a complete image of a based on the amount of medicines and the total number of product stockout and the associated challenges, facilities facilities included in the study. Accordingly, one bin card which provided services for more than a year (i.e., just from for each product was expected from each study facility; the day of the visit) were included in the study. Experience unfortunately, bin cards for two products, morphine from of greater than six months was the inclusion criteria for the health centers and artesunate suppository from both types study participants. of facility, could not be accessed. In Ethiopia, health centers 2.3.2. Exclusion Criteria. Since ART (Antiretroviral Therapy) are not allowed to manage morphine. Additionally, artesu- drugs were in the list of WHO lifesaving medicines, facilities nate suppository was totally unavailable

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us